On Sat, 27 Apr 2024 07:04:10 -0000 (UTC), Lawrence D'Oliveiro
<
ldo@nz.invalid> wrote:
You may have heard of this trial (in NZ and some other countries) of a
new way of using mRNA vaccine technology (the basis for some of the
COVID-19 vaccines): not to prevent a disease in the first place, but >hopefully to cure it (by preventing a recurrence) ><https://www.1news.co.nz/2024/04/27/very-promising-melanoma-vaccine-trial-underway-in-new-zealand/>.
The idea is to stimulate the body’s own immune system to kill the
cancer cells. But this involves determining the mutations present in a >person’s particular tumours, and priming the immune system to target
those. In other words, the treatment has to be personalized for each
patient.
This sounds very like the Car-T-Cell Cancer Therapy developed by the
Malaghan Institute of Medical Research in Wellington. New Zealand
scientists have done great work in a range of areas, and these
developments are among the most beneficial. It is sad to see the new
Government getting rid of some scientists, and pushing for work that
continues to be so closely linked to short term profit generation. Our
public health system should not have to pay profits to a private
company for cancer treatments developed using public risk capital - in
the case of Malaghan supported by money from charities who would want
to benefit all New Zealanders.
--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)